S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Moderna, Inc. Common Stock

MRNA XNAS
$59.17 +5.32 (+9.88%) ▲ 15-min delayed
Open
$54.79
High
$59.41
Low
$54.62
Volume
6.81M
Market Cap
$21.50B

About Moderna, Inc. Common Stock

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 4.7K Website →

Key Financials

Period Revenue Net Income EPS
Q2 2026 $145.00M $-782,000,000 $-1.97
Q1 2026 $389.00M $-1,343,000,000 $-3.40
FY 2025 $1.94B $-2,822,000,000 $-7.26
Q3 2025 $1.02B $-200,000,000 $-0.51

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026
Calendar →

Get MRNA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Moderna, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.